Pure Global

"Le Pulse" Retius coaxial lead thrombus removal catheter - Taiwan Registration e6dffd1c37854fbfddba7bcf62b836f5

Access comprehensive regulatory information for "Le Pulse" Retius coaxial lead thrombus removal catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e6dffd1c37854fbfddba7bcf62b836f5 and manufactured by LEMAITRE VASCULAR, INC.. The authorized representative in Taiwan is HSIN TUNG MEDICAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
e6dffd1c37854fbfddba7bcf62b836f5
Registration Details
Taiwan FDA Registration: e6dffd1c37854fbfddba7bcf62b836f5
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Le Pulse" Retius coaxial lead thrombus removal catheter
TW: โ€œๆจ‚่„ˆโ€้›ท็ทนๆ–ฏๅŒ่ปธๅฐŽ็ทš่ก€ๆ “ๆธ…้™คๅฐŽ็ฎก
Risk Class 2

Registration Details

e6dffd1c37854fbfddba7bcf62b836f5

DHA00601976400

Company Information

United States

Product Details

For details, it is Chinese approved copy of the imitation order.

E Cardiovascular Medicine Science

E.5150 ่ก€ๆ “ๅˆ‡้™ค่ก“ๅฐŽ็ฎก

import

Dates and Status

Apr 03, 2009

Apr 03, 2024